NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS), a biopharmaceutical company with a market capitalization of $2.3 billion ...

Joel Stanley, the founder and former CEO of Charlotte’s Web, is leading an effort to achieve approval from the FDA for a novel treatment to treat autism spectrum ...

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

About the program: Project Equity is a 2021 initiative launched by the FDA's Oncology Center of Excellence to ensure that ...

Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

For generations, Native peoples have been pioneers in medicine, carefully testing traditional healing practices to benefit ...

As part of the planning process, sponsors should propose ... a Confirmatory Trial to Be Underway Prior to Approval? The Confirmatory Trials Guidance also explains that there may be limited ...

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

The mental health clinical trials market is expected to double to $4.27 billion in 2028, up from $2.15 billion in 2018, and ...

The Phase II Clinical Trial Application (CTA) for FG001 in head and neck cancer, announced on October 7, 2024, has been granted approval under the new European process by the Dutch Central Committee ...